Articles

Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial

Ballantyne CM, Banka P, Mendez G, et al.

Journal: 

J Am Coll Cardiol

First published: March 6, 2023  DOI: 10.1016/j.jacc.2023.02.018